# Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole

> **NCT00942773** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00942773
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2010-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942773, "Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00942773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*